Skip to content

Fixed Dose Spinal Bupivacaine for Cesarean Delivery

Fixed Dose Versus Height - Adjusted Dose of Intrathecal Hyperbaric Bupivacaine With Opioid for Cesarean Delivery: a Prospective Double-blinded Randomized Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03231436
Acronym
SpinFix-Bupi
Enrollment
140
Registered
2017-07-27
Start date
2017-07-24
Completion date
2019-06-03
Last updated
2019-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean Section, Spinal Anesthesia

Keywords

intrathecal bupivacaine, hyperbaric bupivacaine, failed spinal

Brief summary

The study is designed to compare the effectiveness of spinal anesthesia performed with fixed dose of hyperbaric bupivacaine regardless of patient's height and weight and anesthesia with the dose of bupivacaine that is adjusted to their height. Our clinical experience shows that spinal anesthesia using specific, relatively high dose of hyperbaric bupivacaine combined with opioid is very effective, regardless of parturient's weight and height, provides very good surgical conditions and assures patient's comfort while the rate of anesthesia - related complications is similar or less. Therefore, using height-adjusted protocols, although preferred in some centres, might not be necessary in order to provide good anaesthesia for cesarean delivery. Fixed dose regimen may have some additional advantages in obstetric anesthesia settings, as many of cesareans are performed out of hours, giving less room for mistakes in less experienced hands. Two groups of parturients undergoing cesarean section are to be compared: anesthetized with fixed-dose regimen (intervention group) and anesthetized with height-adjusted dose regimen (control group). Patients are going to be randomized to one of the above groups, two anesthetists will be involved in anesthetic procedure: anesthetist that looks after the patient throughout the procedure will be blinded to the dose of anesthetic given intrathecally. Therefore his judgment of anesthetic effectiveness is not going to be biased and all patients will receive the same perioperative care in terms of fluid therapy, management of possible anesthesia - related complications and postoperative pain control. Rate of effective spinal anesthetics, defined as adequate block level and no need for additional intraoperative analgesia has been established as primary outcome measure. Secondary outcome measures are rate of complications and amount of opioids used postoperatively. These are going to be statistically compared.

Interventions

DRUGFixed dose of 12.5mg bupivacaine

Spinal anesthesia performed with 12,5mg of bupivacaine with 25mcg fentanyl for cesarean section

DRUGHeight-adjusted dose of bupivacaine

Spinal anesthesia performed with height-adjusted dose of bupivacaine with 25mcg fentanyl for cesarean section

Sponsors

Centre of Postgraduate Medical Education
CollaboratorOTHER
Bartosz Horosz, MD
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* singleton pregnancy above 37Hbd scheduled for elective cesarean section * ASA 1 or 2

Exclusion criteria

* absolute contraindications to spinal anesthesia * delivery in progress * non-singleton pregnancy * BMI\>35 * ultrasound - based estimation of fetal weight below 10 percentile * pregnancy-induced hypertension * more than 2 cesarean sections in patient's medical history * significantly increased risk of obstetric hemorrhage (placenta previa)

Design outcomes

Primary

MeasureTime frameDescription
Adequacy of spinal anesthesia60minLevel of surgical anesthesia at least T5 and no need for additional intraoperative analgesia

Secondary

MeasureTime frameDescription
Number of complications60minHypotension, bradycardia, nausea, vomiting,
Postoperative opioid consumption24hoursTime to the first dose of morphine and total amount of morphine used postoperatively

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026